Form D · Biotechnology
Annovis Bio, Inc.
Berwyn, PA · CIK 0001477845
Offering snapshot reported Apr 25, 2023 · SEC filing
- Reported sold
- $1.06M Offering amount: $1.06M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2023 | Initial | $1,064,952 | No comparison | 6 | SEC filing |
| Mar 15, 2019 | Initial | $530,000 | No comparison | 9 | SEC filing |
| Dec 22, 2017 | Initial | $324,000 | No comparison | 6 | SEC filing |
| Oct 26, 2016 | Initial | $799,200 | No comparison | 14 | SEC filing |
| Jun 5, 2015 | Amendment | $1,067,360 | $567,360vs Jan 5, 2015 | 21 | SEC filing |
| Jan 5, 2015 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Dec 30, 2013 | Amendment | $450,000 | $100,000vs Jun 20, 2013 | 13 | SEC filing |
| Jun 20, 2013 | Initial | $350,000 | No comparison | 12 | SEC filing |
| Apr 26, 2010 | Initial | $706,103 | No comparison | 3 | SEC filing |
| Jan 15, 2010 | Initial | $150,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-479833
Source: Form D, filed Apr 25, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Blake | Director |
| Hal Broderson | Director |
| Claudine Bruck | Director |
| Dhesh Govender | Director |
| Henry Hagopian | Executive |
| Gregory S. Harriman | Director |
| Franz F. Hefti | Director |
| Michael Hoffman | Director |
| Maria Maccecchini | Director, Executive |
| Reid Mc Carthy | Director |
| Barbara S. Schilberg | Director |
| Robert Whelan | Director |
| Mark White | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1055 Westlakes Drive, Suite 300
Berwyn, PA, 19312
Berwyn, PA, 19312